Investor FAQs
Show All

Barinthus Bio Enquiries

Where can I find out more about Barinthus Bio?
More information about Barinthus Bio may be found at barinthusbio.com.
Where can I get the latest corporate news releases and financial reports?
Press releases from Barinthus Bio can be viewed here.
How can I view documents Barinthus Bio has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
SEC filings from Vaccitech can be viewed here.
Who makes up the Barinthus Bio Executive Management team and Board of Directors?
The Barinthus Bio Executive Management team and Board of Directors can be viewed at Our Team.
When is your next earnings release scheduled? How can I receive email updates for this information?
Barinthus Bio's corporate calendar can be viewed here. Please click the Email Alerts link at the top of this page to subscribe to Barinthus Bio updates.
Whom should I contact regarding investor inquiries?
The email address for investment inquiries is IR@barinthusbio.com.
Is Barinthus Bio a PFIC (Passive Foreign Investment Company)?
For 2021, Barinthus Bio was not considered to be a PFIC. For 2022 and 2023, Barinthus Bio was considered a PFIC and the assessment for 2023 can be found here.

Annual Meeting

How can obtain a copy of Barinthus Bio's annual report and proxy?
SEC filings from Barinthus Bio can be viewed here.
When and where will Barinthus Bio hold its next annual meeting?
Barinthus Bio's corporate calendar can be viewed here. For information regarding the Company’s next annual meeting, please refer to the Notice of AGM which can be viewed here.

General

Where is Barinthus Bio's corporate headquarters?
The principal executive office of Barinthus Bio is located at Unit 6-10, Zeus Building, Rutherford Avenue, Harwell, OX11 0DF, United Kingdom.
Where is the Barinthus Bio incorporated?

The United Kingdom.

How do I purchase Barinthus Bio shares?
You can place an order for Barinthus Bio shares through trading platforms that allow trading in NASDAQ listed shares.
When did Barinthus Bio go public?
Barinthus Bio began trading ADSs on the Nasdaq Global Market on 29th April 2021.
What was the price of Barinthus Bio's ADSs at the time that Barinthus Bio went public?
The initial public offering price was $17.00 per ADS.
What is Barinthus Bio's fiscal year?
The fiscal year-end for Barinthus Bio is 31st December. 
Where are Barinthus Bio's ADSs listed and what is the ticker symbol?
Barinthus Bio is listed on The Nasdaq Global [Select] Market under the ticker symbol BRNS.
Who is Barinthus Bio's ADS bank?
The Bank of New York Mellon, 240 Greenwich Street, New York, NY 10286.

Dividends

Does Barinthus Bio pay dividends?
Barinthus Bio does not currently pay dividends and does not intend to pay dividends in the foreseeable future. 
Does Barinthus Bio have a dividend reinvestment plan and how can I participate?
Barinthus Bio does not currently have a dividend reinvestment plan and does not intend to implement such plan in the foreseeable future.

Stock Splits

Has Barinthus Bio undergone a stock split?
Yes. Barinthus Bio completed a 309-for-one stock split effective 3rd of May 2021.

Transfer Agent

Who is Barinthus Bio's transfer agent?
The transfer agent for Barinthus Bio is Computershare Investor Services plc.
Whom do I contact with questions about my stock?
Does Barinthus Bio have a direct stock purchase plan?
Barinthus Bio does not currently have a direct stock purchase plan and does not intend to implement such plan in the foreseeable future.

Auditor/Legal

Who is Barinthus Bio's auditor?
PwC, Reading, United Kingdom.
Who is Barinthus Bio's legal counsel?
Goodwin Procter (UK) LLP, 100 Cheapside, London EC2V 6DY.